To study the efficacy and safety of intranasal administration of 5 mg haloperidol on mild-moderate agitated patients with schizophrenia or schizoaffective disorder in an acute psychiatry unit setting.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335081 | PMC |
Publication Analysis
Top Keywords
efficacy safety
8
safety intranasal
8
acute psychiatry
8
psychiatry unit
8
intranasal haloperidol
4
haloperidol acute
4
unit pilot
4
pilot study
4
study schizophrenic
4
schizophrenic patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!